Notice: This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends Champions Oncology Short Interest DataChampions Oncology (CSBR) has a short interest of 189,500 shares, representing 3.22% of the float (the number of shares available for trading by the public). This marks a -5.30% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 11,735 shares to cover all short positions.Current Short Interest189,500 sharesPrevious Short Interest200,100 sharesChange Vs. Previous Month-5.30%Dollar Volume Sold Short$740,945.00Short Interest Ratio3.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares13,590,000 sharesFloat Size5,880,000 sharesShort Percent of Float3.22%Today's Trading Volume22,552 sharesAverage Trading Volume11,735 sharesToday's Volume Vs. Average192% Short Selling Champions Oncology? Sign up to receive the latest short interest report for Champions Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCSBR Short Interest Over TimeCSBR Days to Cover Over TimeCSBR Percentage of Float Shorted Over Time Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Champions Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024189,500 shares $740,945.00 -5.3%3.2%3.6 $3.91 10/15/2024200,100 shares $908,454.00 -8.1%3.4%3.9 $4.54 9/30/2024217,700 shares $1.06 million -33.6%3.6%4.4 $4.87 9/15/2024327,700 shares $1.65 million +555.4%5.5%6.9 $5.05 8/31/202450,000 shares $211,000.00 +3.3%0.8%8.5 $4.22 8/15/202448,400 shares $217,800.00 No Change0.8%7.6 $4.50 Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 7/31/202448,400 shares $237,644.00 -1.4%0.8%6.4 $4.91 7/15/202449,100 shares $247,955.00 -1.0%0.8%6.5 $5.05 6/30/202449,600 shares $256,432.00 -5.0%0.8%6.9 $5.17 6/15/202452,200 shares $262,566.00 -1.9%0.9%7.2 $5.03 5/31/202453,200 shares $240,996.00 -5.2%0.9%7 $4.53 5/15/202456,100 shares $261,987.00 -6.0%0.9%11.2 $4.67 4/30/202459,700 shares $298,500.00 +5.7%1.0%16.1 $5.00 4/15/202456,500 shares $284,195.00 -2.8%0.9%13.8 $5.03 3/31/202458,100 shares $284,690.00 -7.2%1.0%8.3 $4.90 3/15/202462,600 shares $342,422.00 -3.0%1.0%6 $5.47 2/29/202464,500 shares $365,070.00 +1.7%1.1%5.5 $5.66 2/15/202463,400 shares $359,478.00 -6.6%1.0%5.4 $5.67 1/31/202467,900 shares $394,499.00 +6.1%1.1%5.5 $5.81 1/15/202464,000 shares $429,440.00 -5.7%1.1%5 $6.71 12/31/202367,900 shares $381,591.21 -16.8%1.1%6.1 $5.62 12/15/202381,600 shares $376,176.00 +16.9%1.4%8 $4.61 11/30/202369,800 shares $359,470.00 -1.7%1.2%7.9 $5.15 11/15/202371,000 shares $390,500.00 -2.6%1.2%8.7 $5.50 10/31/202372,900 shares $398,034.00 -6.9%0.7%8.7 $5.46 10/15/202378,300 shares $481,545.00 +5.4%0.8%9.2 $6.15 9/30/202374,300 shares $461,403.00 +25.3%0.7%9.1 $6.21 9/15/202359,300 shares $311,325.00 +3.0%0.6%7.4 $5.25 8/31/202357,600 shares $385,920.00 -22.8%0.6%7 $6.70 8/15/202374,600 shares $484,154.00 -5.1%1.4%8.4 $6.49 7/31/202378,600 shares $510,900.00 +14.9%1.5%8.6 $6.50 7/15/202368,400 shares $452,151.36 +1.5%1.3%8 $6.61 6/30/202367,400 shares $430,012.00 -4.3%1.2%6.9 $6.38 6/15/202370,400 shares $387,904.00 -25.6%1.3%6.9 $5.51 5/31/202394,600 shares $463,540.00 +67.7%1.7%8.9 $4.90 5/15/202356,400 shares $250,416.00 -0.5%1.0%5.2 $4.44 4/30/202356,700 shares $278,964.00 -10.6%1.0%5.3 $4.92 4/15/202363,400 shares $304,320.00 +6.0%1.2%5.2 $4.80 3/31/202359,800 shares $240,396.00 +4.0%1.1%4.6 $4.02 3/15/202357,500 shares $235,750.00 -1.2%1.1%3.5 $4.10Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 2/28/202358,200 shares $270,630.00 +3.2%1.1%2.6 $4.65 2/15/202356,400 shares $232,368.00 +0.5%1.0%2.5 $4.12 1/31/202356,100 shares $230,571.00 +6.3%1.0%2.4 $4.11 1/15/202352,800 shares $227,040.00 -14.0%1.0%2.3 $4.30 12/30/202261,400 shares $276,914.00 -2.4%1.1%3 $4.51 12/15/202262,900 shares $345,950.00 -2.5%1.2%3.2 $5.50 11/30/202264,500 shares $445,050.00 +7.0%1.2%7.2 $6.90 11/15/202260,300 shares $386,523.00 -9.3%1.1%6.6 $6.41 10/31/202266,500 shares $461,510.00 -1.6%1.2%7.2 $6.94 10/15/202267,600 shares $508,352.00 -2.5%1.3%7.5 $7.52 9/30/202269,300 shares $519,750.00 -10.9%1.1%6.8 $7.50 9/15/202277,800 shares $680,750.00 +22.7%1.3%7.9 $8.75 8/31/202263,400 shares $505,932.00 -3.4%1.0%8.7 $7.98 8/15/202265,600 shares $616,640.00 +15.5%1.1%9.9 $9.40 7/31/202256,800 shares $491,888.00 +4.2%1.3%10.7 $8.66 7/15/202254,500 shares $443,624.55 -18.9%1.3%12.4 $8.14 6/30/202267,200 shares $537,606.72 +13.9%1.6%24 $8.00 6/15/202259,000 shares $443,090.00 -22.3%1.4%15.1 $7.51 5/31/202275,900 shares $561,660.00 +16.4%1.3%14.9 $7.40 5/15/202265,200 shares $487,696.00 +12.2%1.1%10.5 $7.48 4/30/202258,100 shares $446,208.00 No Change1.0%8.7 $7.68 4/15/202258,100 shares $479,906.00 -4.9%1.0%8.2 $8.26 3/31/202261,100 shares $496,743.00 -7.1%1.0%8 $8.13 3/15/202265,800 shares $499,422.00 +10.0%1.1%8.7 $7.59 2/28/202259,800 shares $469,430.00 -0.5%1.0%8.4 $7.85 2/15/202260,100 shares $464,573.00 -4.0%1.0%8.6 $7.73 1/31/202262,600 shares $502,052.00 -3.5%1.0%8.9 $8.02 1/15/202264,900 shares $521,147.00 +0.6%1.1%8.8 $8.03 12/31/202164,500 shares $539,220.00 -3.6%1.1%8.4 $8.36 12/15/202166,900 shares $524,496.00 -8.0%1.1%8.5 $7.84 11/30/202172,700 shares $575,784.00 +8.5%1.2%6.2 $7.92 11/15/202167,000 shares $661,290.00 -5.9%1.1%2.7 $9.87 10/29/202171,200 shares $695,624.00 +2.5%1.2%2.8 $9.77 10/15/202169,500 shares $700,560.00 +5.1%1.2%2.5 $10.08 9/30/202166,100 shares $674,881.00 -6.8%1.1%2.2 $10.21 9/15/202170,900 shares $745,159.00 +11.0%1.2%1.5 $10.51 8/31/202163,900 shares $619,191.00 -5.3%1.1%1.3 $9.69 8/13/202167,500 shares $728,325.00 -2.0%1.0%1.7 $10.79 7/30/202168,900 shares $720,005.00 -11.6%1.2%1.7 $10.45 7/15/202177,900 shares $736,934.00 -11.2%1.3%1.8 $9.46 6/30/202187,700 shares $901,556.00 -77.3%1.3%2.1 $10.28 6/15/2021385,800 shares $3.68 million +6.0%9.3%14 $9.54 5/28/2021364,100 shares $3.43 million +0.6%8.8%13 $9.41 5/14/2021362,000 shares $3.28 million +16.6%8.7%11.8 $9.07 4/30/2021310,400 shares $3.49 million +78.3%7.5%9.4 $11.25 4/15/2021174,100 shares $2.01 million +9.1%4.2%5.4 $11.53 3/31/2021159,600 shares $1.84 million +10.6%3.9%4.9 $11.50 3/15/2021144,300 shares $1.72 million -6.2%3.5%4 $11.89 2/26/2021153,800 shares $1.76 million +9.7%3.8%4.2 $11.46 2/12/2021140,200 shares $1.65 million +7.1%3.4%4 $11.76Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 1/29/2021130,900 shares $1.48 million +6.5%2.0%3.8 $11.33 1/15/2021122,900 shares $1.38 million No Change1.9%3.4 $11.23 1/31/2020120,000 shares $910,800.00 -6.5%2.5%2.1 $7.59 1/15/2020120,000 shares $1.02 million -6.5%2.5%2.1 $8.49 12/31/2019128,400 shares $1.06 million +6.7%2.6%2.4 $8.26 CSBR Short Interest - Frequently Asked Questions What is Champions Oncology's current short interest? Short interest is the volume of Champions Oncology shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 189,500 shares of CSBR short. 3.22% of Champions Oncology's shares are currently sold short. Learn More on Champions Oncology's current short interest. What is a good short interest ratio for Champions Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSBR shares currently have a short interest ratio of 4.0. Learn More on Champions Oncology's short interest ratio. What is a good short interest percentage for Champions Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.22% of Champions Oncology's floating shares are currently sold short. Is Champions Oncology's short interest increasing or decreasing? Champions Oncology saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 189,500 shares, a decrease of 5.3% from the previous total of 200,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Champions Oncology's float size? Champions Oncology currently has issued a total of 13,590,000 shares. Some of Champions Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Champions Oncology currently has a public float of 5,880,000 shares. How does Champions Oncology's short interest compare to its competitors? 3.22% of Champions Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Champions Oncology: Sutro Biopharma, Inc. (2.91%), TScan Therapeutics, Inc. (5.19%), Genfit S.A. (0.13%), Molecular Partners AG (0.14%), SOPHiA GENETICS SA (0.05%), Inhibrx, Inc. (9.70%), Lexeo Therapeutics, Inc. (9.82%), Editas Medicine, Inc. (20.88%), Solid Biosciences Inc. (4.40%), Opthea Limited (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Champions Oncology stock? Short selling CSBR is an investing strategy that aims to generate trading profit from Champions Oncology as its price is falling. CSBR shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Champions Oncology? A short squeeze for Champions Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSBR, which in turn drives the price of the stock up even further. How often is Champions Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSBR, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Tevogen Bio Short Squeeze TScan Therapeutics Short Squeeze Sutro Biopharma Short Squeeze Molecular Partners Short Squeeze SOPHiA GENETICS Short Squeeze Genfit Short Squeeze Inhibrx Short Squeeze Zura Bio Short Squeeze Editas Medicine Short Squeeze Solid Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CSBR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
